v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 8,802 $ 22,302
Adjustments to reconcile net income from operating activities:    
Depreciation and amortization 21,917 22,788
Equity-based compensation 14,933 15,142
Amortization of debt issuance costs 647 746
Provision for deferred income taxes 1,708 3,644
Gain on sale of businesses 0 (25,299)
Gain on investment (9,868) 0
Non-cash lease expense 1,576 1,933
Changes in non-cash contingent consideration expense from original estimate 940 1,743
Other non-cash adjustments to net income 2,858 36
Changes in operating assets and liabilities (5,099) (51,311)
Net cash provided by (used in) operating activities 38,414 (8,276)
Cash flows from investing activities:    
Expenditures for property and equipment (2,032) (1,516)
Proceeds from sale of property and equipment 448 1,501
Expenditures for capitalized software (6,536) (6,301)
Purchases of merchant portfolios and residual buyouts 0 (12)
Acquisitions of businesses, net of cash acquired (60,000) (11,000)
Proceeds from sale of Healthcare RCM Business, net of cash sold 0 96,102
Net cash (used in) provided by investing activities (68,120) 78,774
Cash flows from financing activities:    
Proceeds from revolving credit facility 227,833 58,024
Payments on revolving credit facility (113,557) (58,024)
Payments to extinguish exchangeable notes 0 (26,223)
Payments of debt issuance costs 0 (249)
Payments for repurchases of Class A common stock, including related excise taxes (136,895) (37,604)
Net payments for settlement obligations (375) (614)
Cash paid for contingent consideration 0 (800)
Payments for required distributions to members or on behalf of members for tax obligations (2,219) (24,849)
Payments for required distributions to members under the Tax Receivable Agreement (2,524) (9,954)
Proceeds from stock option exercises 129 150
Payments for employees' tax withholdings from net settled stock option exercises and RSU releases (4,576) (4,140)
Net cash used in financing activities (32,184) (104,283)
Net decrease in cash, cash equivalents and restricted cash (61,890) (33,785)
Cash, cash equivalents and restricted cash at beginning of period 67,333 89,597
Cash, cash equivalents and restricted cash at end of period 5,443 55,812
Supplemental disclosure of cash flow information:    
Cash paid for interest 2,486 763
Cash paid for income taxes, net of refunds $ 3,209 $ 35,112